EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Determination of Trimethylamine N-Oxide and Organic Acids Connected with Gut Microbiota in the Urine of Parkinson’s Disease Patients: A Pilot Study

Paulina Gątarek iD, Małgorzata Pawełczyk iD, Barbara Bobrowska-Korczaka iD, Joanna Giebułtowicz iD, Andrzej Głąbiński iD, Joanna Kałużna-Czaplińska iD

International Journal of Molecular Sciences · 10.05.2025 · 26 (10) · 4575

DOI: 10.3390/ijms26104575 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 10.05.2025. Verfasst von Paulina Gątarek und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of General and Ecological Chemistry, Faculty of Chemistry, Lodz University of Technology, 116 Zeromskiego Street, 90-924 Lodz, Poland. Hauptthemen laut MEDLINE: Methylamines, Gastrointestinal Microbiome, Parkinson Disease. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Parkinson’s disease (PD) progression appears closely tied to gut microbiota alterations, with microbial metabolites potentially influencing neurodegeneration. This pilot study employed GC-MS and LC-MS/MS to analyze the urinary levels of gut-derived metabolites—including succinic acid, p-hydroxyphenylacetic acid, homovanillic acid (HVA), vanillylmandelic acid (VMA), adipic acid, and trimethylamine N-oxide (TMAO)—in 20 PD patients versus 20 age-matched controls. The key findings revealed that PD patients exhibited significantly elevated succinic acid (p = 0.0018) and HVA (p = 0.0002) levels alongside reduced TMAO (p = 1.65 × 10−5). Notably, succinic acid showed an inverse correlation with disease severity (Hoehn and Yahr scale: r = −0.63; p = 0.0028), while TMAO demonstrated a strong positive association (r = 0.81; p = 0.00001). The elevated HVA, a dopamine metabolite, may serve as a potential biomarker for monitoring levodopa treatment efficacy. These results suggest that gut microbiota metabolites contribute to PD pathogenesis, with TMAO and succinic acid emerging as promising biomarkers for tracking disease progression. This study highlights the clinical potential of non-invasive urinary metabolite profiling using GC-MS and LC-MS/MS techniques. However, further investigation through larger-scale studies is needed to confirm these findings and elucidate the underlying mechanisms connecting gut microbiota dysbiosis to PD neurodegeneration.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MethylaminesGastrointestinal MicrobiomeParkinson DiseaseHumansMalePilot ProjectsFemaleAgedMiddle AgedTandem Mass SpectrometryBiomarkersSuccinic AcidCase-Control StudiesHomovanillic AcidGas Chromatography-Mass Spectrometry

Stichwörter der Autor:innen

PDParkinson’s diseasechromatographic techniquesdisease progressiongut microbiotametabolites

Substanzen

MethylaminestrimethyloxamineBiomarkersSuccinic AcidHomovanillic Acid

Autor:innen und Institutionen

  • Institute of General and Ecological Chemistry, Faculty of Chemistry, Lodz University of Technology, 116 Zeromskiego Street, 90-924 Lodz, Poland.
  • CONEM Poland Chemistry and Nutrition Research Group, Lodz University of Technology, 90-924 Lodz, Poland.
  • Department of Neurology and Stroke, Medical University of Lodz, 90-549 Lodz, Poland.
  • Department of Toxicology and Food Science, Faculty of Pharmacy, Medical University of Warsaw, Banacha 1 Street, 02-097 Warsaw, Poland.
  • Department of Drug Chemistry, Pharmaceutical and Biomedical Analysis, Faculty of Pharmacy, Medical University of Warsaw, Banacha 1, 02-097 Warsaw, Poland.

ORCID-Profile: Paulina Gątarek, Małgorzata Pawełczyk, Barbara Bobrowska-Korczaka, Joanna Giebułtowicz, Andrzej Głąbiński, Joanna Kałużna-Czaplińska

Zitieren

APA

Gątarek, P., Pawełczyk, M., Bobrowska-Korczaka, B., Giebułtowicz, J., Głąbiński, A., & Kałużna-Czaplińska, J. (2025). The Determination of Trimethylamine N-Oxide and Organic Acids Connected with Gut Microbiota in the Urine of Parkinson’s Disease Patients: A Pilot Study. International Journal of Molecular Sciences, 26(10), 4575. https://doi.org/10.3390/ijms26104575

Vancouver

Gątarek P, Pawełczyk M, Bobrowska-Korczaka B, Giebułtowicz J, Głąbiński A, Kałużna-Czaplińska J. The Determination of Trimethylamine N-Oxide and Organic Acids Connected with Gut Microbiota in the Urine of Parkinson’s Disease Patients: A Pilot Study. International Journal of Molecular Sciences. 2025;26(10):4575. doi:10.3390/ijms26104575

BibTeX
@article{Gtarek2025,
  author = {Gątarek, Paulina and Pawełczyk, Małgorzata and Bobrowska-Korczaka, Barbara and Giebułtowicz, Joanna and Głąbiński, Andrzej and Kałużna-Czaplińska, Joanna},
  title = {The Determination of Trimethylamine N-Oxide and Organic Acids Connected with Gut Microbiota in the Urine of Parkinson’s Disease Patients: A Pilot Study},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {10},
  pages = {4575},
  doi = {10.3390/ijms26104575}
}
Kostenlos starten →